Heterogeneity of glucose metabolism in corticobasal degeneration

Journal of the Neurological Sciences

Volumn 161, Issue 1, 1998, Pages 70-76

  Taniwaki, Takayuki ^a   Yamada, Takeshi ^a   Yoshida, Tsuyoshi ^b   Sasaki, Masayuki ^b   Kuwabara, Yasuo ^b   Nakagawa, Makoto ^b   Mihara, Futoshi ^b   Motomura, Satoru ^c   Shigetou, Hiroshi ^a   Kira, Jun Ichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c KYUSHU ROSAI HOSPITAL   (Japan)

Author keywords

Basal ganglia; Cerebral cortex; Corticobasal degeneration; Glucose metabolism; Magnetic resonance imaging; Positron emission tomography

Indexed keywords

GLUCOSE;

ADULT; AGED; ARTICLE; BASAL GANGLION; BRAIN CORTEX ATROPHY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GLUCOSE METABOLISM; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL LOBE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; THALAMUS;

AGED; BASAL GANGLIA; BRAIN; CEREBRAL CORTEX; FEMALE; GLUCOSE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NERVE DEGENERATION; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032569929     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(98)00269-X     Document Type: Article

References (19)

1. Blin J., Vidailhet M.-J., Pillon B., Dubois B., Feve J.-R., Agid Y. Corticobasal degeneration: Decreased and asymmetrical glucose consumption as studied with PET. Mov Dis. 7:1992;348-354.
2. Brooks D.J. PET studies in progressive supranuclear palsy. J Neural Transm. 42(Suppl):1994;119-134.
3. Brooks R.A. Alternative formula for glucose utilization using labeled deoxyglucose. J Nuclear Med. 23:1982;538-539.
4. Eidelberg D., Dhawan V., Moeller J.R., Sidtis J.J., Ginos J.Z., Strorther S.C., Cederbaum J., Greene P., Fahn S., Powers J.M., Rottenberg D.A. The metabolic landscape of cortico-basal ganglionic degeneration: Regional asymmetries studied with positron emission tomography. J Neurol Neurosurg Psychiatr. 54:1991;856-862.
5. Feany M.B., Mattiace L.A., Dickson D.W. Neuropathologic overlap of progressive supranuclear palsy, Pick's disease and corticobasal degeneration. J Neuropathol Exp Neurol. 55:1996;53-67.
6. Gibb W.R.G., Luthert P.J., Marsden C.D. Corticobasal degeneration. Brain. 112:1989;1171-1192.
7. Gimenez-Roldan S., Mateo D., Benito C., Grandas F., Perez-Gilabert Y. Progressive supranuclear palsy and corticobasal ganglionic degeneration: Differentiation by clinical features and neuroimaging techniques. J Neural Transm. 42(Suppl):1994;79-90.
8. Kanno I., Miura S., Yamamoto S., Iida H., Murakami M., Takahashi K., Uemura K. Design and evaluation of the positron emission tomograph: HEADTOME III. J Comput Assist Tomogr. 9:1985;931-939.
9. Nagasawa H., Tanji H., Nomura H., Saito H., Itoyama Y., Kimura I., Tsuji S., Fujiwara T., Iwata R., Itoh M., Ido T. PET study of cerebral glucose metabolism and fluorodopa uptake in patients with corticobasal degeneration. J Neurol Sci. 139:1996;210-217.
10. Otsuka M., Ichiya Y., Kuwabara Y., Miyake Y., Tahara T., Masuda K., Hosokawa S., Goto I., Kato M., Ichimiya A., Suetsugu M. Cerebral blood flow, oxygen and glucose metabolism with PET in progressive supranuclear palsy. Ann Nuclear Med. 3:1989;111-118.
11. Phelps M.E., Huang S.C., Hoffman E.J., Selin C., Sokoloff L., Kuhl D.E. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: Validation of method. Ann Neurol. 6:1979;371-388.
12. Rebeiz J.J., Kolodny E.H., Richardson E.P. Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol. 18:1968;20-33.
13. Riley D.E., Lang A.E., Lewis A., Resch L., Ashby P., Hornykiewicz O., Black S. Cortico-basal ganglionic degeneration. Neurology. 40:1990;1203-1212.
14. Rinne J.O., Lee M.S., Thompson P.D., Marsden C.D. Corticobasal degeneration. A clinical study of 36 cases. Brain. 117:1994;1183-1196.
15. Sawle G.V., Brooks D.J., Marsden C.D., Frackowiak R.S.J. Corticobasal degeneration. A unique pattern of regional cortical oxygen hypometabolism and striatal fluorodopa uptake demonstrated by positron emission tomography. Brain. 114:1991;541-556.
16. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem. 28:1977;897-916.
17. Taniwaki T., Hosokawa S., Goto I., Fujii N., Otsuka M., Kuwabara Y., Ichiya Y., Hasuo K., Kato M. Positron emission tomography (PET) in 'pure akinesia'. J Neurol Sci. 107:1992;34-39.
18. Watts R.L., Williams R.S., Growdon J.D., Young R.R., Haley E.C., Beal M.F. Corticobasal ganglionic degeneration. Neurology. 35(Suppl 1):1985;178. Abstract.
19. Watts R.L., Mirra S.S., Young R.R., Burger P.C., Villier J.A., Heyman A. Corticobasal ganglionic degeneration with neuronal achromasia: Clinical pathological study of two cases. Neurology. 39(Suppl 1):1989;140. Abstract.